RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells

British Journal of Haematology

Volumn 140, Issue 6, 2008, Pages 682-391

  Chen, Lisa S ^a   Stellrecht, Christine M ^a   Gandhi, Varsha ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cordycepin; Met; Multiple myeloma; Polyadenylation; RNA

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CORDYCEPIN; PROTEIN BCL 2; PROTEIN MCL 1; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; RNA SYNTHESIS;

EID: 39749115845     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06955.x     Document Type: Article

References (46)

1. Balakrishnan, K., Wierda, W.G., Keating, M.J. & Gandhi, V. (2005a) Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA‐directed agent, 8‐NH 2 ‐adenosine. Clinical Cancer Research, 11, 6745–6752.
2. Balakrishnan, K., Stellrecht, C.M., Genini, D., Ayres, M., Wierda, W.G., Keating, M.J., Leoni, L.M. & Gandhi, V. (2005b) Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP. Blood, 105, 4455–4462.
3. Baltz, J.K. & Montello, M.J. (1993) Cladribine for the treatment of hematologic malignancies. Clinical Pharmacology, 12, 805–813.
4. Barlogie, B., Shaughnessy, J., Tricot, G., Jacobson, J., Zangari, M., Anaissie, E., Walker, R. & Crowley, J. (2004) Treatment of multiple myeloma. Blood, 103, 20–32.
5. Borset, M., Hjorth‐Hansen, H., Seidel, C., Sundan, A. & Waage, A. (1996) Hepatocyte growth factor and its receptor c‐Met in multiple myeloma. Blood, 88, 3998–4004.
6. Carrasco, D.R., Tonon, G., Huang, Y., Zhang, Y., Sinha, R., Feng, B., Stewart, J.P., Zhan, F., Khatry, D., Protopopova, M., Protopopov, A., Sukhdeo, K., Hanamura, I., Stephens, O., Barlogie, B., Anderson, K.C., Chin, L., Shaughnessy, Jr, J.D., Brennan, C. & DePinho, R.A. (2006) High‐resolution genomic profiles define distinct clinico‐pathogenetic subgroups of multiple myeloma patients. Cancer Cell, 9, 313–325.
7. Cass, C.E., Selner, M. & Phillips, J.R. (1983) Resistance to 9‐b‐d‐arabinofuranosyladenine in cultured leukemia L 1210 cells. Cancer Research, 43, 4791–4798.
8. Chen, L.S. & Sheppard, T.L. (2004) Chain termination and inhibition of Saccharomyces cerevisiae poly(A) polymerase by C8‐modified ATP analogs. Journal of Biological Chemistry, 279, 40405–40411.
9. Chen, C.‐Y.A. & Shyu, A.‐B. (1995) AU‐rich elements: characterization and importance in mRNA degradation. Trends in Biochemical Sciences, 20, 465–470.
10. Decker, C.J. & Parker, R. (1994) Mechanisms of mRNA degradation in eukaryotes. Trends in Biochemical Sciences, 19, 336–340.
11. Derksen, P.W.B., Keehnen, R.M.J., Evers, L.M., Van Oers, M.H.J., Spaargaren, M. & Pals, S.T. (2002) Cell surface proteoglycan syndecan‐1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma. Blood, 99, 1405–1410.
12. Derksen, P.W.B., De Gorter, D.J.J., Meijer, H.P., Bende, R.J., Van Dijk, M., Lokhorst, H.M., Bloem, A.C., Spaargaren, M. & Pals, S.T. (2003) The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. Leukemia, 17, 764–774.
13. Dimopoulos, M.A., Kantarjian, H.M., Estey, E.H. & Alexanian, R. (1992) 2‐Chlorodeoxyadenosine in the treatment of multiple myeloma. Blood, 80, 1626.
14. El‐Deiry, W.S. (2003) The role of p53 in chemosensitivity and radiosensitivity. Oncogene, 22, 7486–7495.
15. Gandhi, V. & Plunkett, W. (2001) Combination strategies for purine nucleoside analogs. Basic and Clinical Oncology, 26, 195–208.
16. Gandhi, V. & Plunkett, W. (2002) Cellular and clinical pharmacology of fludarabine. Clinical Pharmacokinetics, 41, 93–103.
17. Gandhi, V., Danhauser, L. & Plunkett, W. (1987) Separation of 1‐b‐d‐arabinofuranosylcytosine 5′‐triphosphate and 9‐b‐d‐arabinofuranosyl‐2‐fluoroadenine 5′‐triphosphate in human leukemia cells by high‐performance liquid chromatography. Journal of Chromatography, 413, 293–299.
18. Gandhi, V., Ayres, M., Halgren, R.G., Krett, N.L., Newman, R.A. & Rosen, S.T. (2001) 8‐chloro‐cAMP and 8‐chloro‐adenosine act by the same mechanism in multiple myeloma cells. Cancer Research, 61, 5474–5479.
19. Giordano, S., Di Renzo, M.F., Narsimhan, R.P., Cooper, C.S., Rosa, C. & Comoglio, P.M. (1989a) Biosynthesis of the protein encoded by the c‐met proto‐oncogene. Oncogene, 4, 1383–1388.
20. Giordano, S., Ponzetto, C., Di Renzo, M.F., Cooper, C.S. & Comoglio, P.M. (1989b) Tyrosine kinase receptor indistinguishable from the c‐met protein. Nature (London, United Kingdom), 339, 155–156.
21. Glazer, R.I., Lott, T.J. & Peale, A.L. (1978) Potentiation by 2′‐deoxycoformycin of the inhibitory effect by 3′‐deoxyadenosine (cordycepin) on nuclear RNA synthesis in L1210 cells in vitro. Cancer Research, 38, 2233–2238.
22. Goldman‐Leikin, R.E., Salwen, H.R., Herst, C.V., Variakojis, D., Bian, M.L., Le Beau, M.M., Selvanayagan, P., Marder, R., Anderson, R., Weitzman, S. & Rosen, S.T. (1989) Characterization of a novel myeloma cell line, MM.1. Journal of Laboratory and Clinical Medicine, 113, 335–345.
23. Hiraoka, W., Tanabe, K., Kuwabara, M., Sato, F., Matsuda, A. & Ueda, T. (1988) Metabolic effects of 3′‐deoxyadenosine (cordycepin) and 2‐halo‐3′‐deoxyadenosine on repair of x‐ray‐induced potentially lethal damage in Chinese hamster V79 cells. Radiation Research, 114, 231–239.
24. Huang, Y. & Carmichael, G.C. (1996) Role of polyadenylation in nucleocytoplasmic transport of mRNA. Molecular and Cellular Biology, 16, 1534–1542.
25. Ioannidis, P., Courtis, N., Havredaki, M., Michailakis, E., Tsiapalis, C.M. & Trangas, T. (1999) The polyadenylation inhibitor cordycepin (3′dA) causes a decline in c‐MYC mRNA levels without affecting c‐MYC protein levels. Oncogene, 18, 117–125.
26. Jurado, J., Prieto‐Alamo, M.‐J., Madrid‐Risquez, J. & Pueyo, C. (2003) Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. Journal of Biological Chemistry, 278, 45546–45554.
27. Koc, Y., Urbano, A.G., Sweeney, E.B. & McCaffrey, R. (1996) Induction of apoptosis by cordycepin in ADA‐inhibited TdT‐positive leukemia cells. Leukemia, 10, 1019–1024.
28. Kraut, E.H., Crowley, J.J., Grever, M.R., Keppen, M.D., Bonnet, J.D., Hynes, H.E. & Salmon, S.E. (1990) Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study. Investigational New Drugs, 8, 199–200.
29. Krett, N.L., Davies, K.M., Ayres, M., Ma, C., Nabhan, C., Gandhi, V. & Rosen, S.T. (2004a) 8‐Aminoadenosine is a potential therapeutic agent for multiple myeloma. Molecular Cancer Therapeutics, 3, 1411–1420.
30. Krett, N.L., Ayres, M., Nabhan, C., Ma, C., Nowak, B., Nawrocki, S., Rosen, S.T. & Gandhi, V. (2004b) In vitro assessment of nucleoside analogs in multiple myeloma. Cancer Chemotherapy and Pharmacology, 54, 113–121.
31. Lui, J.C., Wong, J.W., Suen, Y.K., Kwok, T.T., Fung, K.P. & Kong, S.K. (2007) Cordycepin induced eryptosis in mouse erythrocytes through a Ca(2+)‐dependent pathway without caspase‐3 activation. Archives in Toxicology, 81, 859–865.
32. Moalli, P.A., Pillay, S., Weiner, D., Leikin, R. & Rosen, S.T. (1992) A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood, 79, 213–222.
33. Moghul, A., Lin, L., Beedle, A., Kanbour‐Shakir, A., DeFrances, M.C., Liu, Y. & Zarnegar, R. (1994) Modulation of c‐MET proto‐oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c‐MET transcript. Oncogene, 9, 2045–2052.
34. Okada, H. & Mak, T.W. (2004) Pathways of apoptotic and non‐apoptotic death in tumor cells. Nature Reviews. Cancer, 4, 592–603.
35. Parker, W.B., Shaddix, S.C., Chang, C.H., White, E.L., Rose, L.M., Brockman, R.W., Shortnacy, A.T., Montgomery, J.A., Secrist, III, J.A. & Bennett, Jr, L.L. (1991) Effects of 2‐chloro‐9‐(2‐deoxy‐2‐fluoro‐b‐d‐arabinofuranosyl)adenine on K562 cellular metabolism and the inhibition of human ribonucleotide reductase and DNA polymerases by its 5′‐triphosphate. Cancer Research, 51, 2386–2394.
36. Rose, K.M., Bell, L.E. & Jacob, S.T. (1977) Specific inhibition of chromatin‐associated poly(A) synthesis in vitro by cordycepin 5′‐triphosphate. Nature (London, United Kingdom), 267, 178–180.
37. Sachs, A.B., Sarnow, P. & Hentze, M.W. (1997) Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell, 89, 831–838.
38. Shigeura, H.T. & Gordon, C.N. (1965) The effects of 3′‐deoxyadenosine on the synthesis of RNA. Journal of Biological Chemistry, 240, 806–810.
39. Stellrecht, C.M., Rodriguez, Jr, C.O., Ayres, M. & Gandhi, V. (2003) RNA‐directed actions of 8‐chloro‐adenosine in multiple myeloma cells. Cancer Research, 63, 7968–7974.
40. Stellrecht, C.M., Phillip, C.J., Cervantes‐Gomez, F. & Gandhi, V. (2007) Multiple myeloma cell killing by depletion of the MET receptor tyrosine kinase. Cancer Research, 67, 9913–9920.
41. Takahashi, T., Kanazawa, J., Akinaga, S., Tamaoki, T. & Okabe, M. (1999) Antitumor activity of 2‐chloro‐9‐(2‐deoxy‐2‐fluoro‐b‐d‐arabinofuranosyl) adenine, a novel deoxyadenosine analog, against human colon tumor xenografts by oral administration. Cancer Chemotherapy and Pharmacology, 43, 233–240.
42. Thomadaki, H., Tsiapalis, C.M. & Scorilas, A. (2005) Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biological Chemistry, 386, 471–480.
43. Thomadaki, H., Tsiapalis, C.M. & Scorilas, A. (2007) The effect of the polyadenylation inhibitor cordycepin on human Molt‐4 and Daudi leukaemia and lymphoma cell lines. Cancer Chemotherapy and Pharmacology, DOI: 10.1007/s00280-007-0467-y.
44. Wilusz, C.J., Wormington, M. & Peltz, S.W. (2001) The cap‐to‐tail guide to mRNA turnover. Nature Reviews. Molecular and Cell Biology, 2, 237–246.
45. Wu, W.‐C., Hsiao, J.‐R., Lian, Y.‐Y., Lin, C.‐Y. & Huang, B.‐M. (2007) The apoptotic effect of cordycepin on human OEC‐M1 oral cancer cell line. Cancer Chemotherapy and Pharmacology, 60, 103–111.
46. Xie, C. & Plunkett, W. (1995) Metabolism and actions of 2‐chloro‐9‐(2‐deoxy‐2‐fluoro‐b‐d‐arabinofuranosyl)adenine in human lymphoblastoid cells. Cancer Research, 55, 2847–2852.